Radiation Oncology (London, England) | 2019
Adaptive radiotherapy for head and neck cancer reduces the requirement for rescans during treatment due to spinal cord dose
BackgroundPatients treated with radiotherapy for head and neck (H&N) cancer often experience anatomical changes. The potential compromises to Planning Target Volume (PTV) coverage or Organ at Risk (OAR) sparing has prompted the use of adaptive radiotherapy (ART) for these patients. However, implementation of ART is time and resource intensive. This study seeks to define a clinical trigger for H&N re-plans based on spinal cord safety using kV Cone-Beam Computed Tomography (CBCT) verification imaging, in order to best balance clinical benefit with additional workload.MethodsThirty-one H&N patients treated with Volumetric Modulated Arc Therapy (VMAT) who had a rescan CT (rCT) during treatment were included in this study. Contour volume changes between the planning CT (pCT) and rCT were determined. The original treatment plan was calculated on the pCT, CBCT prior to the rCT, pCT deformed to the anatomy of the CBCT (dCT), and rCT (considered the gold standard). The dose to 0.1\u2009cc (D0.1cc) spinal cord was evaluated from the Dose Volume Histograms (DVHs).ResultsThe median dose increase to D0.1cc between the pCT and rCT was 0.7\u2009Gy (inter-quartile range 0.2–1.9\u2009Gy, p\u2009<\u20090.05). No correlation was found between contour volume changes and the spinal cord dose increase. Three patients exhibited an increase of 7.0–7.2\u2009Gy to D0.1cc, resulting in a re-plan; these patients were correctly identified using calculations on the CBCT/dCT.ConclusionsAn adaptive re-plan can be triggered using spinal cord doses calculated on the CBCT/dCT. Implementing this trigger can reduce patient appointments and radiation dose by eliminating up to 90% of additional un-necessary CT scans, reducing the workload for radiographers, physicists, dosimetrists, and clinicians.